-
Je něco špatně v tomto záznamu ?
Preparation and advanced characterization of highly drug-loaded, 3D printed orodispersible tablets containing fluconazole
J. Pyteraf, W. Jamróz, M. Kurek, U. Bąk, J. Loskot, D. Kramarczyk, M. Paluch, R. Jachowicz
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
- MeSH
- 3D tisk * MeSH
- farmaceutická technologie metody MeSH
- flukonazol * MeSH
- poréznost MeSH
- tablety chemie MeSH
- uvolňování léčiv MeSH
- Publikační typ
- časopisecké články MeSH
Due to the possibility of designing various spatial structures, three-dimensional printing can be implemented in the production of customized medicines. Nevertheless, the use of these methods for the production of dosage forms requires further optimization, understanding, and development of printouts' quality verification mechanisms. Therefore, the goal of our work was the preparation and advanced characterization of 3D printed orodispersible tablets (ODTs) containing fluconazole, printed by the fused deposition modeling (FDM) method. We prepared and analyzed 7 printable filaments containing from 10% to 70% fluconazole, used as model API. Obtaining a FDM-printable filament with such a high API content makes our work unique. In addition, we confirmed the 12-month stability of the formulation, which, to our knowledge, is the first study of this type. Next, we printed 10 series of porous tablets containing 50 mg of API from both fresh and stored filaments containing 20 %, 40 %, or 70 % fluconazole. We confirmed the high quality and precision of the printouts using scanning electron microscopy. The detailed analysis of the tablets' disintegration process included the Pharmacopeial test, but also the surface dissolution imaging analysis (SDI) and the test simulating oral conditions performed in own-constructed apparatus. For each composition, we obtained tablets disintegrating in less than 3 min, i.e., meeting the criteria for ODTs required by the European Pharmacopeia. The filaments' storage at ambient conditions did not affect the quality of the tablets. All printed tablets released over 95% of the fluconazole within 30 min. Moreover, the printouts were stable for two weeks.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22031996
- 003
- CZ-PrNML
- 005
- 20230131151507.0
- 007
- ta
- 008
- 230120s2023 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ijpharm.2022.122444 $2 doi
- 035 __
- $a (PubMed)36503848
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Pyteraf, Jolanta $u Department of Pharmaceutical Technology and Biopharmaceutics, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland. Electronic address: jolanta.pyteraf@uj.edu.pl
- 245 10
- $a Preparation and advanced characterization of highly drug-loaded, 3D printed orodispersible tablets containing fluconazole / $c J. Pyteraf, W. Jamróz, M. Kurek, U. Bąk, J. Loskot, D. Kramarczyk, M. Paluch, R. Jachowicz
- 520 9_
- $a Due to the possibility of designing various spatial structures, three-dimensional printing can be implemented in the production of customized medicines. Nevertheless, the use of these methods for the production of dosage forms requires further optimization, understanding, and development of printouts' quality verification mechanisms. Therefore, the goal of our work was the preparation and advanced characterization of 3D printed orodispersible tablets (ODTs) containing fluconazole, printed by the fused deposition modeling (FDM) method. We prepared and analyzed 7 printable filaments containing from 10% to 70% fluconazole, used as model API. Obtaining a FDM-printable filament with such a high API content makes our work unique. In addition, we confirmed the 12-month stability of the formulation, which, to our knowledge, is the first study of this type. Next, we printed 10 series of porous tablets containing 50 mg of API from both fresh and stored filaments containing 20 %, 40 %, or 70 % fluconazole. We confirmed the high quality and precision of the printouts using scanning electron microscopy. The detailed analysis of the tablets' disintegration process included the Pharmacopeial test, but also the surface dissolution imaging analysis (SDI) and the test simulating oral conditions performed in own-constructed apparatus. For each composition, we obtained tablets disintegrating in less than 3 min, i.e., meeting the criteria for ODTs required by the European Pharmacopeia. The filaments' storage at ambient conditions did not affect the quality of the tablets. All printed tablets released over 95% of the fluconazole within 30 min. Moreover, the printouts were stable for two weeks.
- 650 12
- $a flukonazol $7 D015725
- 650 _2
- $a uvolňování léčiv $7 D065546
- 650 _2
- $a tablety $x chemie $7 D013607
- 650 12
- $a 3D tisk $7 D066330
- 650 _2
- $a poréznost $7 D016062
- 650 _2
- $a farmaceutická technologie $x metody $7 D013678
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Jamróz, Witold $u Department of Pharmaceutical Technology and Biopharmaceutics, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland. Electronic address: witold.jamroz@uj.edu.pl
- 700 1_
- $a Kurek, Mateusz $u Department of Pharmaceutical Technology and Biopharmaceutics, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland
- 700 1_
- $a Bąk, Urszula $u Department of Pharmaceutical Technology and Biopharmaceutics, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland. Electronic address: urszula.bak@student.uj.edu.pl
- 700 1_
- $a Loskot, Jan $u Department of Physics, Faculty of Science, University of Hradec Králové, Rokitanského 62, 500 03 Hradec Králové, Czech Republic. Electronic address: jan.loskot@uhk.cz
- 700 1_
- $a Kramarczyk, Daniel $u Faculty of Science and Technology, Institute of Physics, University of Silesia in Katowice, 75 Pułku Piechoty 1a, 41-500 Chorzów, Poland. Electronic address: daniel.kramarczyk@smcebi.edu.pl
- 700 1_
- $a Paluch, Marian $u Faculty of Science and Technology, Institute of Physics, University of Silesia in Katowice, 75 Pułku Piechoty 1a, 41-500 Chorzów, Poland. Electronic address: marian.paluch@us.edu.pl
- 700 1_
- $a Jachowicz, Renata $u Department of Pharmaceutical Technology and Biopharmaceutics, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland. Electronic address: renata.jachowicz@uj.edu.pl
- 773 0_
- $w MED00002359 $t International journal of pharmaceutics $x 1873-3476 $g Roč. 630, č. - (2023), s. 122444
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36503848 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230120 $b ABA008
- 991 __
- $a 20230131151503 $b ABA008
- 999 __
- $a ok $b bmc $g 1891026 $s 1183331
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 630 $c - $d 122444 $e 20221128 $i 1873-3476 $m International journal of pharmaceutics $n Int. j. pharm. $x MED00002359
- LZP __
- $a Pubmed-20230120